![An illustrative photo of vials. Pixabay](https://nocamels.com/wp-content/uploads/2018/05/ampoules-2045833_1280-350x233.jpg)
US Health Authorities Turn To Israeli Universal Flu Vaccine Maker To Ward Off Next Influenza Outbreak
The National Institutes of Health announced a new Phase 2 clinical trial of the M-001 vaccine candidate, developed and produced by BiondVax Pharmaceuticals.
May 08, 2018